FUSION GENOMICS Mission and Vision
To provide global and local healthcare providers the tools they need to perform both population surveillance and personal diagnosis of pathogens to prevent unnecessary deaths and halt the growing problem of disease resistance.
To do this we are developing highly sensitive and massively multiplex DNA/RNA sequencing-based diagnostics that combine our proprietary QUANTUMProbes™ technology with Next Generation Sequencing and our ever-expanding FUSIONCloud™ to bring results directly to the desktop or mobile device.
The use of FUSION’s reliably rapid, highly sensitive and cost effective ONETest™ products will advance the field of molecular diagnostics beyond the limitations and shortcomings of molecular assays currently in use.
A world where humans are healthier because diseases are identified faster and cured sooner through the use of assays using advanced sequencing technologies.
Investors interested in discussing backing for FUSION GENOMICS, please Contact us.